跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CT-300
首页
药物
CT-300
CT-300
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Spider silk fusion protein structures for binding to an organic target
US 9115204 B2
申请人: HEDHAMMAR MY
优先权: 2010
CN
EP
US
WO
8 件公开
Spider silk proteins and methods for producing spider silk proteins
US 8173772 B2
申请人: JOHANSSON JAN
优先权: 2005
US
8 件公开
SPIDER SILK FUSION PROTEIN STRUCTURES INCORPORATING IMMUNOGLOBULIN FRAGMENTS AS AFFINITY LIGANDS
US 2015119554 A1
申请人: SPIBER TECHNOLOGIES AB
优先权: 2012
CN
US
3 件公开
LIQUID PREPARATION FOR ORAL ADMINISTRATION USED FOR CT COLONOGRAPHY AND COMPOSITION FOR GASTROINTESTINAL RADIOGRAPHY
US 2013295018 A1
申请人: AJINOMOTO KK
优先权: 2011
CN
US
2 件公开
Per-oral negative contrast agent for abdominal CT
US 11179483 B2
申请人: LUMENT AB
优先权: 2017
CN
US
2 件公开
Ingredient and production process of Chinese medicinal digestive tract contrast medium
CN 1440815 A
申请人: WANG LEI
优先权: 2002
CN
THERMALLY REVERSIBLE DUAL-STATE LUMINESCENT ORGANIC DONOR-ACCEPTOR CONJUGATES AND METHOD THEREOF
WO 2025008828 A1
申请人: SHIV NADAR INSTITUTION OF EMINENCE DEEMED TO BE UNIV
优先权: 2023
WO
Cubic gold-iron nano preparation, preparation method and application of cubic gold-iron nano preparation in tumor multi-mode imaging
CN 121648306 A
申请人: UNIV BEIJING FRIENDSHIP HOSPITAL CAPITAL MEDICAL
优先权: 2025
CN
药物
反馈